515 related articles for article (PubMed ID: 15545995)
21. Effect of adiponectin on murine colitis induced by dextran sulfate sodium.
Nishihara T; Matsuda M; Araki H; Oshima K; Kihara S; Funahashi T; Shimomura I
Gastroenterology; 2006 Sep; 131(3):853-61. PubMed ID: 16952554
[TBL] [Abstract][Full Text] [Related]
22. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
23. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
[TBL] [Abstract][Full Text] [Related]
25. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
Cenac N; Coelho AM; Nguyen C; Compton S; Andrade-Gordon P; MacNaughton WK; Wallace JL; Hollenberg MD; Bunnett NW; Garcia-Villar R; Bueno L; Vergnolle N
Am J Pathol; 2002 Nov; 161(5):1903-15. PubMed ID: 12414536
[TBL] [Abstract][Full Text] [Related]
26. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
27. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
Castaneda FE; Walia B; Vijay-Kumar M; Patel NR; Roser S; Kolachala VL; Rojas M; Wang L; Oprea G; Garg P; Gewirtz AT; Roman J; Merlin D; Sitaraman SV
Gastroenterology; 2005 Dec; 129(6):1991-2008. PubMed ID: 16344067
[TBL] [Abstract][Full Text] [Related]
28. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
[TBL] [Abstract][Full Text] [Related]
29. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
30. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
31. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
32. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD.
Han S; Wang G; Qiu S; de la Motte C; Wang HQ; Gomez G; Englander EW; Greeley GH
Regul Pept; 2007 Aug; 142(3):131-7. PubMed ID: 17391779
[TBL] [Abstract][Full Text] [Related]
33. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
34. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
35. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
[TBL] [Abstract][Full Text] [Related]
36. Chemically induced mouse models of intestinal inflammation.
Wirtz S; Neufert C; Weigmann B; Neurath MF
Nat Protoc; 2007; 2(3):541-6. PubMed ID: 17406617
[TBL] [Abstract][Full Text] [Related]
37. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
38. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
[TBL] [Abstract][Full Text] [Related]
39. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice.
Kimball ES; Wallace NH; Schneider CR; D'Andrea MR; Hornby PJ
Neurogastroenterol Motil; 2004 Dec; 16(6):811-8. PubMed ID: 15601431
[TBL] [Abstract][Full Text] [Related]
40. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
